These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6530379)

  • 61. Rabbit polymorphonuclear leukocyte chemotactic factor generated in vivo by Bacteroides fragilis lipopolysaccharide. II. Antigenic and biologic properties.
    Sveen K
    Acta Pathol Microbiol Scand B; 1978 Aug; 86(4):237-45. PubMed ID: 99978
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The chemotactic effect of Bacteroides fragilis lipopolysaccharide.
    Hofstad T; Sveen K
    Rev Infect Dis; 1979; 1(2):342-6. PubMed ID: 549186
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clearance of Bacteroides fragilis lipopolysaccharide in vivo.
    Sveen K
    Acta Pathol Microbiol Immunol Scand C; 1985 Feb; 93(1):7-11. PubMed ID: 3984751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of neuraminidase in haemagglutination and adherence to colon WiDr cells by Bacteroides fragilis.
    Namavar F; Van der Bijl MW; Appelmelk BJ; De Graaff J; MacLaren DM
    J Med Microbiol; 1994 Jun; 40(6):393-6. PubMed ID: 8006931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response.
    McGhee JR; Michalek SM; Kiyono H; Eldridge JH; Colwell DE; Williamson SI; Wannemuehler MJ; Jirillo E; Mosteller LM; Spalding DM
    Microbiol Immunol; 1984; 28(3):261-80. PubMed ID: 6234450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression.
    Ochoa-Repáraz J; Mielcarz DW; Ditrio LE; Burroughs AR; Begum-Haque S; Dasgupta S; Kasper DL; Kasper LH
    J Immunol; 2010 Oct; 185(7):4101-8. PubMed ID: 20817872
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune response to endotoxin isolated from Bacteroides fragilis in the pregnant guinea pig.
    Beckmann I; Meisel-Mikołajczyk F; Leszczynski P; Wallenburg HC
    Int Arch Allergy Appl Immunol; 1990; 93(2-3):222-6. PubMed ID: 2099349
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enzyme linked immunosorbent assay & indirect fluorescence assay for rapid diagnosis of Bacteroides fragilis infections.
    Ayyagari A; Khanna T; Devi S
    Indian J Med Res; 1992 Jan; 95():34-40. PubMed ID: 1577518
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serological activity of antigens isolated from 11 Bacteroides vulgatus strains.
    Rouyan GS; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1991; 40(1-2):77-83. PubMed ID: 1725095
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detection of specific bacterial antigen in urine of patients infected with Bacteroides fragilis.
    Rissing JP; Buxton TB; Harris RW; Shockley RK
    J Infect Dis; 1984 Jun; 149(6):929-34. PubMed ID: 6736683
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Haemagglutination by the Bacteroides fragilis group.
    Vel WA; Namavar F; Marian A; Verweij-van Vught JJ; Pubben AN; MacLaren DM
    J Med Microbiol; 1986 Mar; 21(2):105-7. PubMed ID: 3005581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of a polysaccharide antigen from Bacteroides gingivalis.
    Schifferle RE; Reddy MS; Zambon JJ; Genco RJ; Levine MJ
    J Immunol; 1989 Nov; 143(9):3035-42. PubMed ID: 2509563
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunochemical relationship of three antigens purified from Pasteurella multocida strain P-1059.
    Tsuji M; Matsumoto M
    Am J Vet Res; 1988 Sep; 49(9):1510-5. PubMed ID: 3146936
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunochemical characterization of Bacteroides vulgatus cell-surface antigens.
    Rouyan GS; Kaca W; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1998; 47(1):55-63. PubMed ID: 9691430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice.
    Jotwani R; Tanaka Y; Watanabe K; Tanaka-Bandoh K; Kato N; Ueno K
    Microbiol Immunol; 1994; 38(9):763-6. PubMed ID: 7854218
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Difficulties in the serodiagnosis of infection with the fragilis group of Bacteroides.
    Elhag KM; Bahar AM; Mahajan KK
    J Med Microbiol; 1987 Sep; 24(2):125-31. PubMed ID: 3309321
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antigenic mimicry of ubiquitin by the gut bacterium Bacteroides fragilis: a potential link with autoimmune disease.
    Stewart L; D M Edgar J; Blakely G; Patrick S
    Clin Exp Immunol; 2018 Nov; 194(2):153-165. PubMed ID: 30076785
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemical, immunobiological and antigenic characterizations of lipopolysaccharides from Bacteroides gingivalis strains.
    Fujiwara T; Ogawa T; Sobue S; Hamada S
    J Gen Microbiol; 1990 Feb; 136(2):319-26. PubMed ID: 1691266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunological study of antisera to to artificial O-antigen of Pseudomonas aeruginosa.
    Edvabnaya LS; Stanislavskii ES; Lany B; Schiller B; Bichowicz I
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):163-8. PubMed ID: 6166668
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The biological activity of a liposomal complete core lipopolysaccharide vaccine.
    Erridge C; Stewart J; Bennett-Guerrero E; McIntosh TJ; Poxton IR
    J Endotoxin Res; 2002; 8(1):39-46. PubMed ID: 11981444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.